XXVII Zjazd Polskiego Towarzystwa Hematologów i Transfuzjologów | Sesja sponsorowana firmy Novartis - Relacje cyfrowe

Management of the adverse events ofthe TKI therapy in CML patients

Saglio Giuseppe

Management of the adverse events ofthe TKI therapy in CML patients
Myelofibrosis: Long term treatment benefits with targeted therapy and management of adverse reactions

Harrison Claire

Myelofibrosis: Long term treatment benefits with targeted therapy and management of adverse reactions